comparemela.com

Latest Breaking News On - Passport health travel clinics - Page 1 : comparemela.com

Immuron nets 136% increase in global sales this year compared to financial year 2022

Globally integrated biopharmaceuticals company Immuron Ltd (NASDAQ:IMRN, ASX:IMC) has had a bumper year for its over-the-counter gastrointestinal and.

Immuron Fy23 Sales Increase 136% On Fy22 Sales

Immuron Fy23 Sales Increase 136% On Fy22 Sales
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Immuron Q3 Sales reach 150% of 1H Sales

Highlights: Australian Q3 FY23 sales of A$577 k North American Q3 FY23 Travelan® sales of A$298 k Global Q3 YTD FY23 sales of A$1.46 M represent an increase of 239% compared with the. | April 6, 2023

Immuron North American Travelan Sales up 494% and Global sales up 431%

11.07.2022 - Highlights: North American FY22 Travelan sales increased by +494% to $0.6MGlobal sales increased by 431% to $0.9MAustralian FY22 sales increased by 318% to $0.3M MELBOURNE, Australia, July 11, 2022 (GLOBE NEWSWIRE) - Immuron Limited (ASX: .

Immuron Travelan® Global sales up 216%

Key Highlights: North American Travelan® sales up by 185% YoY in Q3 FY22Global sales up 216% YoY in Q3 FY22.YTD March 31, FY22 worldwide Travelan® sales reached AU $392K, increasing. | April 27, 2022

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.